2.0
Dec 18, 2024
Current employee, more than 5 years
Washington, DC
Recommend
CEO approval
Business outlook
Pros
Great technology and clinical backing
Cons
Total micromanagement and overpromise of pay knowing the comp plan is broken. Bad administration with zero sense of business